Search results
Author(s):
Matthew J Budoff
Added:
1 year ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical…
View more
Aortic Endograft Infection: Timely Recognition Is Key
Author(s):
Salwan Al-Hani
,
Luai Madanat
,
Aiden Van Loo
,
et al
Added:
1 year ago
Medical Image
MI and Non-obstructive Coronary Arteries
Author(s):
Yetunde A Fatade
,
Noah A Newman
,
Nidhi H Patel
,
et al
Added:
1 year ago
Review Article
Added:
10 months ago
Source:
ESC Congress 2025 Scientific Programme
ESC Congress 2025 has released twenty-eight late-breaking trials and science sessions to be presented in August 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Late-Breaking Clinical Science: Inflammation and Immune Biomarkers in Cardiovascular Risk PredictionFriday 29th August, 08:15am – 09:45am (CEST…
View more